Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Colitis and hepatitis caused by methyldopa

H L Bonkowsky, J Brisbane

    JAMA
    |October 4, 1976
    PubMed
    Summary
    This summary is machine-generated.

    Methyldopa can cause severe colitis and hepatitis, indicated by allergy symptoms like fever and rash. Drug cessation led to symptom remission, highlighting methyldopa

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Seizure management in the hepatic porphyrias: results from a cell-culture model of porphyria.

    Neurology·1984
    Same author

    Iron loading of cultured hepatocytes. Effect of iron on 5-aminolaevulinate synthase is independent of lipid peroxidation.

    The Biochemical journal·1983
    Same author

    Iron and the liver: acute effects of iron-loading on hepatic heme synthesis of rats. Role of decreased activity of 5-aminolevulinate dehydrase.

    The Journal of clinical investigation·1983
    Same author

    Decreased activity of uroporphyrinogen decarboxylase caused by 2,4,5,3',4'-pentabromobiphenyl in chick embryo hepatocyte cultures. Difference in activity in intact or homogenized cells.

    FEBS letters·1983
    Same author

    Increases in cytochrome p-450 in cultured hepatocytes mediated by 3- and 4-carbon alcohols.

    Biochemical pharmacology·1982
    Same author

    Neurologic manifestations of acute porphyria.

    Seminars in liver disease·1982

    Area of Science:

    • Hepatology
    • Gastroenterology
    • Clinical Pharmacology

    Background:

    • Methyldopa is a commonly prescribed antihypertensive medication.
    • Hepatitis is a known adverse effect of methyldopa therapy.
    • The potential for methyldopa to induce colitis is less understood.

    Observation:

    • A 55-year-old male patient experienced recurrent episodes of acute, severe colitis and hepatitis.
    • These episodes temporally correlated with the administration of methyldopa.
    • Associated symptoms included fever, skin rash, and eosinophilia, suggestive of a drug-induced hypersensitivity reaction.

    Findings:

    • The patient's symptoms and clinical signs resolved completely upon discontinuation of methyldopa.
    • This case suggests methyldopa is a potential cause of drug-induced acute colitis.

    Related Experiment Videos

  • The findings expand the known spectrum of methyldopa-associated organ toxicity.

    • Implications:

    • Clinicians should consider methyldopa as a potential etiology for acute colitis, particularly in patients with concurrent hepatitis or allergic symptoms.
    • Awareness of this association may improve diagnosis and management of drug-induced gastrointestinal and hepatic injury.
    • Further investigation into the mechanisms of methyldopa-induced colitis is warranted.